e-LEA3D: A computational-aided drug design web server

Nucleic Acids Research

Volumn 38, Issue SUPPL. 2, 2010, Pages

  Douguet, Dominique ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BINDING SITE; COMBINATORIAL LIBRARY; COMPUTER AIDED DESIGN; DIGITAL FILTERING; DRUG DESIGN; DRUG RESEARCH; DRUG SCREENING; GENETIC ALGORITHM; INFORMATION SERVICE; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; VIRTUAL REALITY; BIOLOGY; CHEMISTRY; COMPUTER INTERFACE; COMPUTER PROGRAM; INTERNET;

BENZOIC ACID; COMPUTATIONAL BIOLOGY; DRUG DESIGN; INTERNET; LIGANDS; PHARMACEUTICAL PREPARATIONS; RECEPTORS, RETINOIC ACID; SOFTWARE; USER-COMPUTER INTERFACE;

BENZOIC ACID; DRUG; LIGAND; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ALPHA;

EID: 77954282775     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkq322     Document Type: Article

References (37)

1. Lipinski, C. and Hopkins, A. (2004) Navigating chemical space for biology and medicine. Nature, 432, 855-861.
2. Triggle, D.J. (2009) The chemist as astronaut: searching for biologically useful space in the chemical universe. Biochem. Pharmacol., 78, 217-223.
3. Blum, L.C. and Reymond, J.L. (2009) 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13. J. Am. Chem. Soc., 131, 8732-8733.
4. Hartenfeller, M., Proschak, E., Schuller, A. and Schneider, G. (2008) Concept of combinatorial de novo design of drug-like molecules by particle swarm optimization. Chem. Biol. Drug Des., 72, 16-26.
5. Masek, B.B., Shen, L., Smith, K.M. and Pearlman, R.S. (2008) Sharing chemical information without sharing chemical structure. J. Chem. Inf. Model, 48, 256-261.
6. Wang, R., Gao, Y. and Lai, L. (2000) LigBuilder: a multi-purpose program for Structure-based drug design. J. Mol. Model, 6, 498-516.
7. Glen, R.C. and Payne, A.W. (1995) A genetic algorithm for the automated generation of molecules within constraints. J. Comput. Aided Mol. Des., 9, 181-202.
8. Pegg, S.C., Haresco, J.J. and Kuntz, I.D. (2001) A genetic algorithm for structure-based de novo design. J. Comput. Aided Mol. Des., 15, 911-933.
9. Clark, D.E., Frenkel, D., Levy, S.A., Li, J., Murray, C.W., Robson, B., Waszkowycz, B. and Westhead, D.R. (1995) PRO-LIGAND: an approach to de novo molecular design. 1. Application to the design of organic molecules. J. Comput. Aided Mol. Des., 9, 13-32.
10. Stahl, M., Todorov, N.P., James, T., Mauser, H., Boehm, H.J. and Dean, P.M. (2002) A validation study on the practical use of automated de novo design. J. Comput. Aided Mol. Des., 16, 459-478.
11. Irwin, J.J. and Shoichet, B.K. (2005) ZINC-a free database of commercially available compounds for virtual screening. J. Chem. Inf. Model, 45, 177-182.
12. Honma, T. (2003) Recent advances in de novo design strategy for practical lead identification. Med. Res. Rev., 23, 606-632.
13. Leach, A.R., Bryce, R.A. and Robinson, A.J. (2000) Synergy between combinatorial chemistry and de novo design. J. Mol. Graph Model, 18, 358-367, 526.
14. van Hoorn, W.P. and Bell, A.S. (2009) Searching chemical space with the Bayesian Idea Generator. J. Chem. Inf. Model, 49, 2211-2220.
15. Schmidt, M.F. and Rademann, J. (2009) Dynamic template-assisted strategies in fragment-based drug discovery. Trends Biotechnol, 27, 512-521.
16. Manetsch, R., Krasinski, A., Radic, Z., Raushel, J., Taylor, P., Sharpless, K.B. and Kolb, H.C. (2004) In situ click chemistry: enzyme inhibitors made to their own specifications. J. Am. Chem. Soc., 126, 12809-12818.
17. Mocharla, V.P., Colasson, B., Lee, L.V., Roper, S., Sharpless, K.B., Wong, C.H. and Kolb, H.C. (2004) In situ click chemistry: enzyme-generated inhibitors of carbonic anhydrase II. Angew. Chem. Int. Ed. Engl., 44, 116-120.
18. Bourne, Y., Kolb, H.C., Radic, Z., Sharpless, K.B., Taylor, P. and Marchot, P. (2004) Freeze-frame inhibitor captures acetylcholinesterase in a unique conformation. Proc. Natl Acad. Sci. USA, 101, 1449-1454.
19. Richon, A.B. (2008) Current status and future direction of the molecular modeling industry. Drug Discov. Today, 13, 665-669.
20. Richon, A.B. (2008) An early history of the molecular modeling industry. Drug Discov. Today, 13, 659-664.
21. Tschinke, V. and Cohen, N.C. (1993) The NEWLEAD program: a new method for the design of candidate structures from pharmacophoric hypotheses. J. Med. Chem., 36, 3863-3870.
22. Villoutreix, B.O., Renault, N., Lagorce, D., Sperandio, O., Montes, M. and Miteva, M.A. (2007) Free resources to assist structure-based virtual ligand screening experiments. Curr. Protein Pept. Sci., 8, 381-411.
23. Irwin, J.J., Shoichet, B.K., Mysinger, M.M., Huang, N., Colizzi, F., Wassam, P. and Cao, Y. (2009) Automated docking screens: a feasibility study. J. Med. Chem., 52, 5712-5720.
24. Li, H., Gao, Z., Kang, L., Zhang, H., Yang, K., Yu, K., Luo, X., Zhu, W., Chen, K., Shen, J. et al. (2006) TarFisDock: a web server for identifying drug targets with docking approach. Nucleic Acids Res., 34, W219-W224.
25. Douguet, D., Munier-Lehmann, H., Labesse, G. and Pochet, S. (2005) LEA3D: a computer-aided Ligand design for structure-based drug design. J. Med. Chem., 48, 2457-2468.
26. Korb, O., Stutzle, T. and Exner, T.E. (2009) Empirical scoring functions for advanced protein-ligand docking with PLANTS. J. Chem. Inf. Model, 49, 84-96.
27. Rarey, M., Kramer, B., Lengauer, T. and Klebe, G. (1996) A fast flexible docking method using an incremental construction algorithm. J. Mol. Biol., 261, 470-489.
28. Leite, T.B., Gomes, D., Miteva, M.A., Chomilier, J., Villoutreix, B.O. and Tuffery, P. (2007) Frog: a FRee Online druG 3D conformation generator. Nucleic Acids Res., 35, W568-W572.
29. Roche, O., Schneider, P., Zuegge, J., Guba, W., Kansy, M., Alanine, A., Bleicher, K., Danel, F., Gutknecht, E.M., Rogers-Evans, M. et al. (2002) Development of a virtual screening method for identification of "frequent hitters" in compound libraries. J. Med. Chem., 45, 137-142.
30. Viswanadhan, V.N., Ghose, A.K., Revankar, G.R. and Robins, R.K. (1989) Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. J. Chem. Inf. Comput. Sci., 29, 163-172.
31. Moos, W.H., Hurt, C.R. and Morales, G.A. (2009) Combinatorial chemistry: oh what a decade or two can do. Mol. Divers., 13, 241-245.
32. Dolinsky, T.J., Nielsen, J.E., McCammon, J.A. and Baker, N.A. (2004) PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res., 32, W665-W667.
33. Schneidman-Duhovny, D., Dror, O., Inbar, Y., Nussinov, R. and Wolfson, H.J. (2008) PharmaGist: a webserver for ligand-based pharmacophore detection. Nucleic Acids Res., 36, W223-W228.
34. Bauer, R.A., Bourne, P.E., Formella, A., Frommel, C., Gille, C., Goede, A., Guerler, A., Hoppe, A., Knapp, E.W., Poschel, T. et al. (2008) Superimpose: a 3D structural superposition server. Nucleic Acids Res., 36, W47-W54.
35. Sperandio, O., Petitjean, M. and Tuffery, P. (2009) wwLigCSRre: a 3D ligand-based server for hit identification and optimization. Nucleic Acids Res., 37, W504-W509.
36. Miteva, M.A., Violas, S., Montes, M., Gomez, D., Tuffery, P. and Villoutreix, B.O. (2006) FAF-Drugs: free ADME/tox filtering of compound collections. Nucleic Acids Res., 34, W738-W744.
37. Wang, R., Lai, L. and Wang, S. (2002) Further development and validation of empirical scoring functions for structure-based binding affinity prediction. J. Comput. Aided Mol. Des., 16, 11-26.